EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer: impact of treatment modalities and resection status

Tarik Sammour iD, Oliver Peacock iD, Brian K Bednarski, Arvind Dasari, Prajnan Das, Benny Johnson, Grace L Smith, George J Chang iD, John Skibber, Y Nancy You

Colorectal Disease · 2025

DOI: 10.1111/codi.70110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colorectal Disease, 2025. Verfasst von Tarik Sammour und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Rectal Neoplasms, Quality of Life, Neoplasm Recurrence, Local, Salvage Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health/National Cancer Institute MD Anderson Cancer Center Support Grant, The University of Texas MD Anderson Cancer Center - Duncan Family Foundation Cancer Survivorship Research Seed Money Grant, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Recurrent rectal cancer (RRC) can be morbid and optimising cancer survivorship is a priority. The longitudinal trajectories of survivorship associated with RRC have not been prospectively depicted.

Methods

We prospectively enrolled patients with RRC. Participants self‐reported quality of life (QOL) using validated European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 and CR29, and pain using the Brief Pain Inventory, at baseline and then every 6 months for up to 5 years or until death. Baseline scores and the longitudinal trajectory of scores were examined using linear mixed‐effects modelling.

Results

Among 104 patients, 73 (70.2%) received multimodality salvage treatment with curative intent, while the remainder received best palliative treatments. Curative‐intent salvage including surgery was associated with a 30‐day operative morbidity rate of 49% and a 5‐year overall survival of 51%. Patients undergoing curative‐intent salvage versus palliative treatments did not differ in baseline QOL or pain, but the longitudinal trajectory after curative‐intent salvage showed sustained improvement of QOL and symptoms over time. This contrasted with the initial transient improvement but persistent decline with palliative treatments. Baseline QOL was significantly impacted by the anatomical site of RRC, with posterior location associated with worst QOL ( P = 0.012). Long‐term QOL was impacted by anatomical site and status of residual tumour. Pain scores were worse among men.

Conclusion

Trajectories of cancer survivorship for patients with RRC diverge, mainly influenced by anatomical site of the RCC, residual tumour status, and ability to complete curative‐intent salvage. These should inform treatment planning. Optimising selection and success of multimodality therapy remains the cornerstone for durable cancer survivorship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsQuality of LifeNeoplasm Recurrence, LocalSalvage TherapySurvivorshipCancer SurvivorsHumansMaleFemaleMiddle AgedProspective StudiesAgedLongitudinal StudiesPalliative CareCombined Modality TherapyAged, 80 and overAdultProctectomy

Stichwörter der Autor:innen

EORTCexenterationquality of liferectal cancerrecurrent rectal cancer

Autor:innen und Institutionen

  • Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Gastrointestinal Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Tarik Sammour, Oliver Peacock, George J Chang

Förderung

  • National Institutes of Health/National Cancer Institute MD Anderson Cancer Center Support Grant
  • The University of Texas MD Anderson Cancer Center - Duncan Family Foundation Cancer Survivorship Research Seed Money Grant
  • National Institutes of Health

Zitieren

APA

Sammour, T., Peacock, O., Bednarski, B. K., Dasari, A., Das, P., Johnson, B., Smith, G. L., Chang, G. J., Skibber, J., & You, Y. N. (2025). Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer: impact of treatment modalities and resection status. Colorectal Disease. https://doi.org/10.1111/codi.70110

Vancouver

Sammour T, Peacock O, Bednarski BK, Dasari A, Das P, Johnson B, et al. Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer: impact of treatment modalities and resection status. Colorectal Disease. 2025. doi:10.1111/codi.70110

BibTeX
@article{Sammour2025,
  author = {Sammour, Tarik and Peacock, Oliver and Bednarski, Brian K and Dasari, Arvind and Das, Prajnan and Johnson, Benny and Smith, Grace L and Chang, George J and Skibber, John and You, Y Nancy},
  title = {Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer: impact of treatment modalities and resection status},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.70110}
}
Kostenlos starten →